戻る Agenda
Session 8
Session Chair(s)
Toshiko Ishibashi, PhD, RN
Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan
![Kumiko Okada](/_Images/member/Generic_Image_Missing-Profile.jpg)
Kumiko Okada
Study Manager, Clinical Operations
Pfizer R&D, Japan
Speaker(s)
![Toshiaki Nakaoka](/_Images/member/Generic_Image_Missing-Profile.jpg)
Presentation8-1
Toshiaki Nakaoka
Chugai Clinical Research Center Co., Ltd., Japan
NA
![Yumi Ikezaki](/_Images/member/Generic_Image_Missing-Profile.jpg)
Presentation8-2
Yumi Ikezaki
Kissei Pharmaceutical Co., Ltd., Japan
Clinical Development Div. Clinical Research Dept.
![Kengo Fukui](/_Images/member/Generic_Image_Missing-Profile.jpg)
Presentation8-3
Kengo Fukui
Pfizer R&D Japan G.K., Japan
Clinical Operations
![Hiroyuki Fujimoto](/_Images/member/Generic_Image_Missing-Profile.jpg)
Presentation8-4
Hiroyuki Fujimoto
Daiichi Sankyo Co., Ltd, Japan
Medical Affairs Planning Department